SBC Medical Group Holdings Inc (SBC) stock

SBCNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as SBCWW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3014% below fair value

$7.35+2.01 (+37.64%)

Close on Nov 13, 2026Market cap $755.93MP/E 15.6Yield –

SBC Medical EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

SBC Medical's EV/EBITDA was 5.4× on Nov 11, 2026, against 3.8× a year earlier. Over the last 3 years it ranged from 2.5× to 14.3×, with a median of 4.7×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	5.4×	+0.3
2025	Dec 31, 2025	5.1×	+0.3
2024	Dec 31, 2024	4.7×	–

Where these numbers come from

Parsed from the XBRL in SBC Medical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SBC.

Compare: SBC vs LFMD · SBC vs CCM · SBC vs AIRS · SBC vs STLN · SBC vs BMGL

Revenue growth-6.9% · median 23.6%

Gross margin71.9% · median 73.4%

Operating margin37.3% · median -4.7%

Net margin28.0% · median -5.7%

Company	Revenue	Growth
STLN	$620.45M	+34.6%
LFMD	$189.26M	+23.6%
SBC	$175.17M	-6.9%
AIRS	$147.68M	-6.3%
CCM	–	–
BMGL	–	–

Company

Next earnings (est.): Mar 26, 2027, before open
Exchange: Nasdaq
Industry: Services-Offices & Clinics of Doctors of Medicine
Fiscal year ends: December 31
Employees: 863
Auditor: MaloneBailey, LLP
SEC CIK: 1930313

Advertisement
300 × 250

See a number that looks wrong?

SBC Medical EV/EBITDA

EV/EBITDA at the end of each year

More SBC Medical figures